Search research articles
Contact Us
Filters
Showing results (131-140 of 191) with videos related to
Page
of 20
Sort By:
Breast Cancer Research : BCR
|
December 5, 2024
Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ
Marija Debeljak, Soonweng Cho, Bradley M Downs, et al.
Journal of the National Cancer Institute
|
January 24, 2018
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer
Linda S Lindström, Christina Yau, Kamila Czene, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib
Lisa A Carey, Donald A Berry, Constance T Cirrincione, et al.
Journal of the National Cancer Institute
|
September 2, 2017
Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study
Melissa A Troester, Xuezheng Sun, Emma H Allott, et al.
JAMA Oncology
|
March 28, 2024
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials
Aranzazu Fernandez-Martinez, Mattia Rediti, Gong Tang, et al.
Cell
|
April 7, 2018
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M Malta, Artem Sokolov, Andrew J Gentles, et al.
JAMA Oncology
|
May 5, 2017
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas
Dezheng Huo, Hai Hu, Suhn K Rhie, et al.
Nature Genetics
|
September 8, 2015
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A Moffitt, Raoud Marayati, Elizabeth L Flate, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2018
Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
Maki Tanioka, Cheng Fan, Joel S Parker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2024
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)
A Fernandez-Martinez, M Tanioka, S G Ahn, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 191) with videos related to
Sort By:
Page
of 20
Breast Cancer Research : BCR
|
December 5, 2024
Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ
Marija Debeljak, Soonweng Cho, Bradley M Downs, et al.
Journal of the National Cancer Institute
|
January 24, 2018
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer
Linda S Lindström, Christina Yau, Kamila Czene, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2015
Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib
Lisa A Carey, Donald A Berry, Constance T Cirrincione, et al.
Journal of the National Cancer Institute
|
September 2, 2017
Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study
Melissa A Troester, Xuezheng Sun, Emma H Allott, et al.
JAMA Oncology
|
March 28, 2024
Tumor Intrinsic Subtypes and Gene Expression Signatures in Early-Stage ERBB2/HER2-Positive Breast Cancer: A Pooled Analysis of CALGB 40601, NeoALTTO, and NSABP B-41 Trials
Aranzazu Fernandez-Martinez, Mattia Rediti, Gong Tang, et al.
Cell
|
April 7, 2018
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M Malta, Artem Sokolov, Andrew J Gentles, et al.
JAMA Oncology
|
May 5, 2017
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas
Dezheng Huo, Hai Hu, Suhn K Rhie, et al.
Nature Genetics
|
September 8, 2015
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A Moffitt, Raoud Marayati, Elizabeth L Flate, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 25, 2018
Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer
Maki Tanioka, Cheng Fan, Joel S Parker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2024
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)
A Fernandez-Martinez, M Tanioka, S G Ahn, et al.
Page
of 20